Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis - No Study Results Posted

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (RAVE)

This study is ongoing, but not recruiting participants.

Study NCT00104299 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received: February 24, 2005 Last Updated: May 13, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	March 2010
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)